Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy (Q33408040)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy |
scientific article |
Statements
1 reference
Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy (English)
1 reference
Emmanuelle Bompas
1 reference
George D Demetri
1 reference
Peter Reichardt
1 reference
Sant P Chawla
1 reference
Arthur P Staddon
1 reference
Thierry Alcindor
1 reference
Richard F Riedel
1 reference
Binh Bui-Nguyen
1 reference
Lee D Cranmer
1 reference
Daniel Rushing
1 reference
Yang Song
1 reference
Ruey-Min Lee
1 reference
Scot Ebbinghaus
1 reference
Joseph E Eid
1 reference
John W Loewy
1 reference
Frank G Haluska
1 reference
Pierre F Dodion
1 reference
1 reference
Identifiers
1 reference